Marlowe PLC Total Voting Rights
January 02 2025 - 6:05AM
RNS Regulatory News
RNS Number : 9328R
Marlowe PLC
02 January 2025
2 January 2025
Marlowe plc
Total Voting
Rights
In accordance with section 5.6.1 of
the Financial Conduct Authority's (FCA) Disclosure Guidance and
Transparency Rules (DTRs), Marlowe plc ("Marlowe" or the "Group") hereby notifies the market of
the following:
The Group's issued capital as at 31
December 2024 consists of 82,927,430
ordinary shares of 50p each ("Ordinary Shares") with voting rights
attached. Of these, no Ordinary Shares are held exclusive of voting
rights in Treasury.
Therefore, the total number of
voting rights in Marlowe as at 31 December 2024 is
82,927,430.
Shareholders may use the figure
of 82,927,430 Ordinary
Shares as the denominator for the calculations by which they will
determine if they are required to notify their interest, or a
change to their interest, in Marlowe under the
DTRs.
|
For
further information:
|
|
|
|
|
|
Marlowe plc
|
|
|
Lord Ashcroft, Interim Non-Executive
Chair
Adam Councell, Chief Financial
Officer
Benjamin Tucker, Head of Investor
Relations & Strategy
|
www.marloweplc.com
Tel: +44
(0)20 3813 8498
IR@marloweplc.com
|
|
Cavendish Capital Markets Limited (Nominated Adviser &
Broker)
|
|
Ben Jeynes
George Lawson
|
Tel: +44
(0)20 7220 0500
|
|
|
|
|
FTI
Consulting
|
|
|
Nick Hasell
Alex Le May
|
Tel: +44
(0)20 3727 1340
|
About Marlowe plc
Marlowe is a leader in
business-critical services which ensures compliance with strict
regulations and insurance requirements across Fire Safety &
Security and Water & Air Hygiene. The Group has a national
footprint and serves approximately 27,000 customers across office
complexes, high streets & leisure facilities, manufacturing
plants and industrial estates, and include thousands of SMEs, local
authorities, facilities management providers, multi-site NHS trusts
and FTSE 100 companies.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
TVRBTMBTMTMMBIA
Marlowe (LSE:MRL)
Historical Stock Chart
From Dec 2024 to Jan 2025
Marlowe (LSE:MRL)
Historical Stock Chart
From Jan 2024 to Jan 2025
